A new instrument for the assessment of patient-defined benefit in the treatment of allergic rhinitis.
Beteiligte Einrichtungen
Abstract
Allergic rhinitis (AR) is a common disease that affects health-related quality of life (HRQoL). Current and future health policy demands the assessment of patient-relevant treatment benefit for evaluation of treatments.
Bibliografische Daten
| Originalsprache | Englisch |
|---|---|
| Aufsatznummer | 5 |
| ISSN | 0105-4538 |
| Status | Veröffentlicht - 2011 |
| pubmed | 21121931 |
|---|
